Monday, December 09, 2019 3:07:22 AM
Without doubt the FDA inaction has killed hemp and CBD stocks.
75% of consumers think the farm bill made CBD FDA approved. They believe they are safe and the product is regulated.
This has allowed start up companies, many of whom are frauds, to sell their product with consumer confidence it is safe and monitored. It's not.
Legit companies, that behave like their product is an FDA approved dietary supplement, are hemmoraging sales to pop up companies with zero investment.
Additionally lack of legality is keeping companies like CVSI from uplisting.
The market is expanding rapidly, but bad actors are benefiting.
However, the House passed an amendment in the budget forcing the FDA to address this. And the Senate is adding similar but even more focused language. They vote for a budget deal by December 20th. If they course correct the FDA we should expect guidance within 120-180 days. Maybe sooner. The FDA has been approving drugs in 10 weeks, they can make this happen if they want.
75% of consumers think the farm bill made CBD FDA approved. They believe they are safe and the product is regulated.
This has allowed start up companies, many of whom are frauds, to sell their product with consumer confidence it is safe and monitored. It's not.
Legit companies, that behave like their product is an FDA approved dietary supplement, are hemmoraging sales to pop up companies with zero investment.
Additionally lack of legality is keeping companies like CVSI from uplisting.
The market is expanding rapidly, but bad actors are benefiting.
However, the House passed an amendment in the budget forcing the FDA to address this. And the Senate is adding similar but even more focused language. They vote for a budget deal by December 20th. If they course correct the FDA we should expect guidance within 120-180 days. Maybe sooner. The FDA has been approving drugs in 10 weeks, they can make this happen if they want.
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
